Drug delivery devices: Here is West’s plan for success


West SelfDose SmartDose drug delivery devices

The SmartDose platform (left) and the SelfDose patient-controlled injector (right) [Images courtesy of West]

West Pharmaceutical Services is betting that an embrace of human factors engineering and experiential design will allow its drug delivery devices such as its SmartDose and SelfDose to stand apart from the crowd.

People are more likely to take their medications properly if a device is easy to use, Eric Resnick, vice president and chief technology officer at West (Exton, Pa.), explained this week at MD&M East in New York.

That’s a strong value argument for health providers because medication adherence is an important part of efficiently and effectively managing patient populations – something that public and private health insurers alike are increasingly requiring.

“It isn’t just about the drug and the container and the device. It’s integrating all those but then thinking patient, caregiver, family … the ecosystem behind it,” Resnick said.

Get the full story on our sister site, Drug Delivery Business.

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Speak Your Mind